Cancer Medicine - Research

Experimental Therapeutics

20 Recent Publications

This is a list of the 20 publications most recently added to the Research Profiles database. This shows the publication activity that is ongoing at the institution.The source of publications for this application is Scopus.

  Select All    |   Export

• 1.

  2013

  Vildan Betul Yenigun; Bulent Ozpolat; Gamze Torun Kose

  Response of CD44⁺/CD24^-/low breast cancer stem/progenitor cells to tamoxifen-and doxorubicin-induced autophagy

  International Journal of Molecular Medicine. 2013;31(6):1477-1483.

• 2.

  2013

  Mian M.K. Shahzad; Yong-Hyun Shin; Koji Matsuo; Chunhua Lu; Masato Nishimura; De-Yo Shen; Yu Kang; Wei Hu; Edna M. Mora; Cristian Rodriguez-Aguayo; et al.

  Biological significance of HORMA domain containing protein 1 (HORMAD1) in epithelial ovarian carcinoma

  Cancer Letters. 2013;330(2):123-129.

• 3.

  2013

  Subash C. Gupta; Kanokkarn Phromnoi; Bharat B. Aggarwal

  Morin inhibits STAT3 tyrosine 705 phosphorylation in tumor cells through activation of protein tyrosine phosphatase SHP1

  Biochemical Pharmacology. 2013;85(7):898-912.

• 4.

  2013

  Hong Zhou; Suhendan Ekmekcioglu; John W Marks; Khalid A Mohamedali; Kaushal Asrani; Keeley K Phillips; Sharron A N Brown; Emily Cheng; Michele B Weiss; Walter N Hittelman; et al.

  The TWEAK receptor Fn14 is a therapeutic target in melanoma: Immunotoxins targeting Fn14 receptor for malignant melanoma treatment

  Journal of Investigative Dermatology. 2013;133(4):1052-1062.

• 5.

  2013

  Izabela Fokt; Stanislaw Skora; Charles Conrad; Timothy Madden; Mark Emmett; Waldemar Priebe

  D-Glucose and d-mannose-based metabolic probes. Part 3: Synthesis of specifically deuterated d-glucose, d-mannose, and 2-deoxy-d-glucose

  Carbohydrate Research. 2013;368:111-119.

• 6.

  2013

  Bilge Eker; Robert Meissner; Arnaud Bertsch; Kapil Mehta; Philippe Renaud

  Label-Free Recognition of Drug Resistance via Impedimetric Screening of Breast Cancer Cells

  PLoS ONE. 2013;8(3).

• 7.

  2013

  Midan Ai; Ke Liang; Yang Lu; Songbo Qiu; Zhen Fan

  Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition

  Cancer Biology and Therapy. 2013;14(3):237-245.

• 8.

  2013

  Katrien Van Roosbroeck; Jeroen Pollet; George A Calin

  MiRNAs and long noncoding RNAs as biomarkers in human diseases

  Expert Review of Molecular Diagnostics. 2013;13(2):183-204.

• 9.

  2013

  Pijus K. Mandal; Zhiyong Ren; Xiaomin Chen; Kumar Kaluarachchi; Warren S.-L. Liao; John S. McMurray

  Structure-activity studies of phosphopeptidomimetic prodrugs targeting the src homology 2 (SH2) domain of signal transducer and activator of transcription 3 (Stat3)

  International Journal of Peptide Research and Therapeutics. 2013;19(1):3-12.

• 10.

  2013

  Vivek R. Yadav; Bokyung Sung; Sahdeo Prasad; Ramaswamy Kannappan; Sung-Gook Cho; Mingyao Liu; Madan M. Chaturvedi; Bharat B. Aggarwal

  Erratum: Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor (Journal of Molecular Medicine (2010) 88: 12 (1243-1253) DOI: 10.1007/s00109-010-0669-3)

  Journal of Molecular Medicine. 2013;91(3):407-408.

• 11.

  2013

  Cristina Ivan; Wei Hu; Justin Bottsford-Miller; Behrouz Zand; Heather J. Dalton; Tao Liu; Jie Huang; Alpa M. Nick; Gabriel Lopez-Berestein; Robert L. Coleman; et al.

  Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer

  Gynecologic Oncology. 2013;128(3):506-511.

• 12.

  2013

  Tarrik M. Zaid; Tsz-Lun Yeung; Melissa S. Thompson; Cecilia S. Leung; Tom Harding; Ngai-Na Co; Rosie S. Schmandt; Suet-Ying Kwan; Cristian Rodriguez-Aguay; Gabriel Lopez-Berestein; et al.

  Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer

  Clinical Cancer Research. 2013;19(4):809-820.

• 13.

  2013

  Laura S. Angelo; David S. Maxwell; Ji Yuan Wu; Duoli Sun; David H. Hawke; Ian E. McCutcheon; John M. Slopis; Zhenghong Peng; William G. Bornmann; Razelle Kurzrock

  Binding partners for curcumin in human schwannoma cells: Biologic Implications

  Bioorganic and Medicinal Chemistry. 2013;21(4):932-939.

• 14.

  2013

  Robert S. Hudson; Ming Yi; Natalia Volfovsky; Robyn L. Prueitt; Dominic Esposito; Stefano Volinia; Chang-Gong Liu; Aaron J. Schetter; Katrien Van Roosbroeck; Robert M. Stephens; et al.

  Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer

  Molecular Cancer. 2013;12(1).

• 15.

  2013

  Da Yang; Yan Sun; Limei Hu; Hong Zheng; Ping Ji; Chad V. Pecot; Yanrui Zhao; Sheila Reynolds; Hanyin Cheng; Rajesha Rupaimoole; et al.

  Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer

  Cancer Cell. 2013;23(2):186-199.

• 16.

  2013

  Y Cao; J W Marks; Z Liu; L H Cheung; W N Hittelman; M G Rosenblum

  Design optimization and characterization of Her2/neu-targeted immunotoxins: comparative in vitro and in vivo efficacy studies

  Oncogene. 2013.

• 17.

  2013

  Betty Lamothe; Yun Ju Lai; Min Xie; Michael D. Schneider; Bryant G. Darnay

  TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis

  Molecular and Cellular Biology. 2013;33(3):582-595.

• 18.

  2013

  Lynette M. Moore; Virpi Kivinen; Yuexin Liu; Matti Annala; David Cogdell; Xiuping Liu; Chang-Gong Liu; Raymond Sawaya; Olli Yli-Harja; Ilya Shmulevich; et al.

  Transcriptome and small RNA deep sequencing reveals deregulation of miRNA biogenesis in human glioma

  Journal of Pathology. 2013;229(3):449-459.

• 19.

  2013

  Gregory J. Tsongalis; George Calin; Pierre Cordelier; Carlo Croce; Federico Monzon; Anna E. Szafranska-Schwarzbach

  MicroRNA analysis: Is it ready for prime time?

  Clinical Chemistry. 2013;59(2):343-347.

• 20.

  2013

  Brittany C. Parker; Matti J. Annala; David E. Cogdell; Kirsi J. Granberg; Yan Sun; Ping Ji; Xia Li; Joy Gumin; Hong Zheng; Limei Hu; et al.

  The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma

  Journal of Clinical Investigation. 2013;123(2):855-865.